Onasemnogene abeparvovec for treating spinal muscular atrophy (HST15)
Evidence-based recommendations on onasemnogene abeparvovec (Zolgensma) for treating spinal muscular atrophy in babies
Search results
67 results
-
-
Elosulfase alfa for treating mucopolysaccharidosis type IVa (HST2)
Evidence-based recommendations on elosulfase alfa (Vimizim) for treating mucopolysaccharidosis type IVa in adults and children
-
Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene (HST3)
Evidence-based recommendations on ataluren (Translarna) for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene in people aged
-
Strimvelis for treating adenosine deaminase deficiency–severe combined immunodeficiency (HST7)
Evidence-based recommendation on Strimvelis for adenosine deaminase deficiency–severe combined immunodeficiency
-
Burosumab for treating X-linked hypophosphataemia in children and young people (HST8)
Evidence-based recommendations on burosumab (Crysvita) for treating X-linked hypophosphataemia (XLH) in children and young people
-
Inotersen for treating hereditary transthyretin amyloidosis (HST9)
Evidence-based recommendations on inotersen (Tegsedi) for stage 1 and stage 2 polyneuropathy in adults with hereditary transthyretin amyloidosis
-
Migalastat for treating Fabry disease (HST4)
Evidence-based recommendations on migalastat (Galafold) for treating Fabry disease in people over 16
-
Eliglustat for treating type 1 Gaucher disease (HST5)
Evidence-based recommendations on eliglustat (Cerdelga) for treating type 1 Gaucher disease in adults
-
Asfotase alfa for treating paediatric-onset hypophosphatasia (HST6)
Evidence-based recommendations on asfotase alfa (Strensiq) for treating paediatric-onset hypophosphatasia in adults and children
-
Patisiran for treating hereditary transthyretin amyloidosis (HST10)
Evidence-based recommendations on patisiran (Onpattro) for treating hereditary transthyretin amyloidosis in adults with stage 1 and stage 2 polyneuropathy
-
Eculizumab for treating atypical haemolytic uraemic syndrome (HST1)
Evidence-based recommendations on eculizumab (Soliris) for treating atypical haemolytic uraemic syndrome in adults and children
-
Voretigene neparvovec for treating inherited retinal dystrophies caused by RPE65 gene mutations (HST11)
Evidence-based recommendations on voretigene neparvovec (Luxturna) for RPE65-mediated inherited retinal dystrophies in people with vision loss caused by inherit
-
Volanesorsen for treating familial chylomicronaemia syndrome (HST13)
Evidence-based recommendations on volanesorsen (Waylivra) for treating familial chylomicronaemia syndrome in adults
-
Metreleptin for treating lipodystrophy (HST14)
Evidence-based recommendations on metreleptin (Myalepta) for treating lipodystrophy in children and adults
-
Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 (HST12)
Evidence-based recommendations on cerliponase alfa (Brineura) for treating neuronal ceroid lipofuscinosis type 2 in children
-
HumiGard for preventing inadvertent perioperative hypothermia (MTG31)
Evidence-based recommendations on HumiGard for preventing inadvertent perioperative hypothermia
-
HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography (MTG32)
Evidence-based recommendations on HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography
-
Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C (MTG27)
Evidence-based recommendations on Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C
-
Ambu aScope4 Broncho for use in unexpected difficult airways (MTG14)
Evidence-based recommendations on the Ambu aScope4 Broncho for use in unexpected difficult airways
-
SecurAcath for securing percutaneous catheters (MTG34)
Evidence-based recommendations on SecurAcath for securing percutaneous catheters (central venous catheters/CVCs)
-
Memokath-051 stent for ureteric obstruction (MTG35)
Evidence-based recommendations on Memokath-051 stent for treating ureteric obstruction
-
Peristeen transanal irrigation system for managing bowel dysfunction (MTG36)
Evidence-based recommendations on the Peristeen transanal irrigation system for managing bowel dysfunction
-
Thopaz+ portable digital system for managing chest drains (MTG37)
Evidence-based recommendations on Thopaz+ for managing chest drains
-
Neuropad for detecting preclinical diabetic peripheral neuropathy (MTG38)
Evidence-based recommendations on Neuropad for detecting preclinical diabetic peripheral neuropathy
-
iFuse for treating chronic sacroiliac joint pain (MTG39)
Evidence-based recommendations on iFuse for treating chronic sacroiliac joint pain
-
Spectra Optia for automatic red blood cell exchange in people with sickle cell disease (MTG28)
Evidence-based recommendations on Spectra Optia for automated red blood cell exchange in people with sickle cell disease
-
GreenLight XPS for treating benign prostatic hyperplasia (MTG29)
Evidence-based recommendations on GreenLight XPS for treating benign prostatic hyperplasia
-
XprESS multi sinus dilation system for treating chronic sinusitis (MTG30)
Evidence-based recommendations on the XprESS multi-sinus dilation system for treating chronic sinusitis after medical treatment has failed
-
The Debrisoft monofilament debridement pad for use in acute or chronic wounds (MTG17)
Evidence-based recommendations on the Debrisoft monofilament debridement pad for use in acute or chronic wounds
-
The geko device for reducing the risk of venous thromboembolism (MTG19)
Evidence-based recommendations on the geko device for reducing the risk of venous thromboembolism
-
moorLDI2-BI: a laser doppler blood flow imager for burn wound assessment (MTG2)
Evidence-based recommendations on moorLDI2-BI: a laser doppler blood flow imager for burn wound assessment
-
Parafricta Bootees and Undergarments to reduce skin breakdown in people with or at risk of pressure ulcers (MTG20)
Evidence-based recommendations on Parafricta Bootees and Undergarments to reduce skin breakdown in people with or at risk of pressure ulcers
-
VibraTip for testing vibration perception to detect diabetic peripheral neuropathy (MTG22)
Evidence-based recommendations on VibraTip for testing vibration perception to detect diabetic peripheral neuropathy
-
The Sherlock 3CG Tip Confirmation System for placement of peripherally inserted central catheters (MTG24)
Evidence-based recommendations on The Sherlock 3CG Tip Confirmation System for placement of peripherally inserted central catheters
-
Tegaderm CHG securement dressing for vascular access sites in critically ill adults (MTG25)
Evidence-based recommendations on The 3M Tegaderm CHG IV securement dressing for central venous and arterial catheter insertion sites
-
Mepilex Border Heel and Sacrum dressings for preventing pressure ulcers (MTG40)
Evidence-based recommendations on Mepilex Border Heel and Sacrum dressings for preventing pressure ulcers
-
Senza spinal cord stimulation system for delivering HF10 therapy to treat chronic neuropathic pain (MTG41)
Evidence-based recommendations on the Senza spinal cord stimulation system for delivering HF10 therapy to treat chronic neuropathic pain
-
UrgoStart for treating diabetic foot ulcers and leg ulcers (MTG42)
Evidence-based recommendations on UrgoStart for treating diabetic foot ulcers and leg ulcers
-
PICO negative pressure wound dressings for closed surgical incisions (MTG43)
Evidence-based recommendations on PICO negative pressure wound dressings for closed surgical incisions
-
Curos for preventing infections when using needleless connectors (MTG44)
Evidence-based recommendations on Curos for preventing infections when using needleless connectors
-
Endocuff Vision for assisting visualisation during colonoscopy (MTG45)
Evidence-based decisions on Endocuff Vision for assisting visualisation during colonoscopy
-
gammaCore for cluster headache (MTG46)
Evidence-based recommendations on gammaCore for cluster headache
-
Episcissors-60 for mediolateral episiotomy (MTG47)
Evidence-based recommendations on Episcissors-60 for mediolateral episiotomy
-
PneuX to prevent ventilator-associated pneumonia (MTG48)
Evidence-based recommendations on PneuX to prevent ventilator-associated pneumonia
-
Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia (MTG49)
Evidence-based recommendations on Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia
-
Danis stent for acute oesophageal variceal bleeding (MTG57)
Evidence-based recommendations on Danis stent for acute oesophageal variceal bleeding
-
UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia (MTG58)
Evidence-based recommendations on UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia
-
Ambulight PDT for the treatment of non-melanoma skin cancer (MTG6)
Evidence-based recommendations on Ambulight PDT for the treatment of non-melanoma skin cancer
-
Plus Sutures for preventing surgical site infection (MTG59)
Evidence-based recommendations on Plus Sutures for preventing surgical site infection
-
The MIST Therapy system for the promotion of wound healing (MTG5)
Evidence-based recommendations on the MIST Therapy system for the promotion of wound healing